These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Successful Combination of Systemic Agents for the Treatment of Atopic Dermatitis Resistant to Dupilumab Therapy. Gori N; Chiricozzi A; Malvaso D; D'Urso DF; Caldarola G; De Simone C; Peris K Dermatology; 2021; 237(4):535-541. PubMed ID: 33477153 [TBL] [Abstract][Full Text] [Related]
24. A Patch Testing Initiative for the Investigation of Allergic Contact Dermatitis in a UK Allergy Practice: A Retrospective Study. Watts TJ; Watts S; Thursfield D; Haque R J Allergy Clin Immunol Pract; 2019 Jan; 7(1):89-95. PubMed ID: 30201159 [TBL] [Abstract][Full Text] [Related]
25. Atopy Associated With Positive Patch Test and Possible Allergic Contact Dermatitis. Kirchhof MG; de Gannes GC J Cutan Med Surg; 2018; 22(4):405-410. PubMed ID: 29457485 [TBL] [Abstract][Full Text] [Related]
26. Patch Testing in a Patient on Dupilumab. Hoot JW; Douglas JD; Falo LD Dermatitis; 2018; 29(3):164. PubMed ID: 29570490 [No Abstract] [Full Text] [Related]
27. Allergic contact dermatitis in adults with and without atopic dermatitis: Evaluation of the Spanish Contact Dermatitis Registry (REIDAC). Chicharro P; Munera-Campos M; Zaragoza-Ninet V; Giménez-Arnau A; González-Pérez R; Miquel-Miquel FJ; Córdoba-Guijarro S; Sanz-Sánchez T; Ruiz-González I; Silvestre-Salvador JF; Serra-Baldrich E; Borrego L; Pastor-Nieto MA; Ortiz de Frutos FJ; Mercader-García P; Heras-Mendaza F; Fernández-Redondo V; Rodríguez-Serna M; Hervella-García M; Carrascosa JM; Gallego-Descalzo MA; García-Doval I; Sánchez-Pérez J Contact Dermatitis; 2024 Nov; 91(5):404-411. PubMed ID: 39138883 [TBL] [Abstract][Full Text] [Related]
28. Allergic contact dermatitis to detergents: a multicenter study to assess prevalence. Belsito DV; Fransway AF; Fowler JF; Sherertz EF; Maibach HI; Mark JG; Mathias CG; Rietschel RL; Storrs FJ; Nethercott JR J Am Acad Dermatol; 2002 Feb; 46(2):200-6. PubMed ID: 11807430 [TBL] [Abstract][Full Text] [Related]
29. Recall dermatitis at patch test sites in an atopic dermatitis patient treated with dupilumab. Collantes-Rodríguez C; Jiménez-Gallo D; Ossorio-García L; Villegas-Romero I; Linares-Barrios M Contact Dermatitis; 2019 Jan; 80(1):69-70. PubMed ID: 30334260 [No Abstract] [Full Text] [Related]
30. Prevalence and trend of allergen sensitization in patients referred for patch testing with a final diagnosis of psoriasis: North American Contact Dermatitis Group data, 2001-2016. Silverberg JI; Hou A; DeKoven JG; Warshaw EM; Maibach HI; Atwater AR; Belsito DV; Zug KA; Taylor JS; Sasseville D; Fransway AF; DeLeo VA; Pratt MD; Reeder MJ; Fowler JF; Zirwas MJ; Marks JG; Dunnick CA; Houle MC Contact Dermatitis; 2021 Oct; 85(4):435-445. PubMed ID: 33931870 [TBL] [Abstract][Full Text] [Related]
32. Cutaneous delayed-type hypersensitivity in patients with atopic dermatitis: reactivity to topical preservatives. Shaughnessy CN; Malajian D; Belsito DV J Am Acad Dermatol; 2014 Jan; 70(1):102-7. PubMed ID: 24220722 [TBL] [Abstract][Full Text] [Related]
33. Allergic contact dermatitis in Danish children referred for patch testing - a nationwide multicentre study. Simonsen AB; Deleuran M; Mortz CG; Johansen JD; Sommerlund M Contact Dermatitis; 2014 Feb; 70(2):104-11. PubMed ID: 24102181 [TBL] [Abstract][Full Text] [Related]
34. Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-Week results from the Dutch BioDay registry. Ariëns LFM; van der Schaft J; Spekhorst LS; Bakker DS; Romeijn GLE; Kouwenhoven TA; Kamsteeg M; Voorberg AN; Oosting AJ; de Ridder I; Sloeserwij A; Haeck I; Thijs JL; Schuttelaar MLA; de Bruin-Weller MS J Am Acad Dermatol; 2021 Apr; 84(4):1000-1009. PubMed ID: 32946967 [TBL] [Abstract][Full Text] [Related]
35. Real-world experience of dupilumab treatment for atopic dermatitis in adults: a retrospective analysis of patients' records. Wang C; Kraus CN; Patel KG; Ganesan AK; Grando SA Int J Dermatol; 2020 Feb; 59(2):253-256. PubMed ID: 31286499 [TBL] [Abstract][Full Text] [Related]
36. A case series of dupilumab-treated allergic contact dermatitis patients. Goldminz AM; Scheinman PL Dermatol Ther; 2018 Nov; 31(6):e12701. PubMed ID: 30246906 [TBL] [Abstract][Full Text] [Related]
37. Facial and neck erythema associated with dupilumab treatment: A systematic review. Jo CE; Finstad A; Georgakopoulos JR; Piguet V; Yeung J; Drucker AM J Am Acad Dermatol; 2021 May; 84(5):1339-1347. PubMed ID: 33428978 [TBL] [Abstract][Full Text] [Related]
38. Dupilumab after the 2017 approval for the treatment of atopic dermatitis: what's new and what's next? van der Schaft J; Thijs JL; de Bruin-Weller MS; Balak DMW Curr Opin Allergy Clin Immunol; 2019 Aug; 19(4):341-349. PubMed ID: 31145194 [TBL] [Abstract][Full Text] [Related]
39. Effect of dupilumab on asthma and aeroallergen sensitization in pediatric atopic dermatitis patients: Results of the BioDay registry. van der Rijst LP; de Winter-de Groot KM; Zuithoff NPA; de Bruin-Weller MS; de Graaf M Pediatr Allergy Immunol; 2024 Jun; 35(6):e14178. PubMed ID: 38899688 [TBL] [Abstract][Full Text] [Related]